REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,216,266 | +198.0% | 24,376 | +24.5% | 0.01% | +300.0% |
| Q4 2022 | $743,616 | +38.0% | 19,574 | +10.4% | 0.00% | +100.0% |
| Q2 2022 | $539,000 | -8.0% | 17,725 | +194.7% | 0.00% | -50.0% |
| Q3 2020 | $586,000 | +2690.5% | 6,015 | +4019.9% | 0.00% | – |
| Q1 2020 | $21,000 | -94.3% | 146 | -91.9% | 0.00% | -100.0% |
| Q4 2019 | $371,000 | +1586.4% | 1,813 | +574.0% | 0.00% | – |
| Q3 2019 | $22,000 | -46.3% | 269 | -38.6% | 0.00% | – |
| Q2 2019 | $41,000 | +10.8% | 438 | 0.0% | 0.00% | – |
| Q1 2019 | $37,000 | +1750.0% | 438 | +338.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |